TargetGene Biotechnologies Overview

  • Founded
  • 2012
Founded
  • Status
  • Private
  • Employees
  • 6
Employees
  • Latest Deal Type
  • Corporate
  • Financing Rounds
  • 1

TargetGene Biotechnologies General Information

Description

Provider of DNA editing services in living organisms. The company specializes in providing gene-specific DNA genome editing services in living organisms.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Corporate Backed or Acquired
Primary Industry
Biotechnology
Primary Office
  • Oppenheimer 10
  • Floor 3
  • Rehovot
  • Israel
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

TargetGene Biotechnologies Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore TargetGene Biotechnologies‘s full profile, request access.

Request a free trial

TargetGene Biotechnologies Executive Team (2)

Name Title Board Seat Contact Info
Yoel Shiboleth Ph.D Co-Founder & Chief Executive Officer
Dan Weinthal Ph.D Co-Founder & Chief Operating Officer
To view TargetGene Biotechnologies’s complete executive team members history, request access »

TargetGene Biotechnologies Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

TargetGene Biotechnologies Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore TargetGene Biotechnologies‘s full profile, request access.

Request a free trial